Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Avelumab first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): Analysis of time to end of next-line therapy in JAVELIN Bladder 100.
- Authors
- Grivas, P[Grivas, Petros]; Park, SH[Park, Se Hoon]; Voog, E[Voog, Eric]; Kopyltsov, E[Kopyltsov, Evgeny]; Gurney, H[Gurney, Howard]; Muniz, DQB[Muniz, David Queiroz Borges]; Rolland, F[Rolland, Frederic]; Als, AB[Als, Anne Birgitte]; Valderrama, BP[Valderrama, Begona P.]; Wang, J[Wang, Jing]; Costa, NM[Costa, Nuno Matos]; Laliberte, RJ[Laliberte, Robert J.]; Di Pietro, A[Di Pietro, Alessandra]; Powles, T[Powles, Thomas]; Bellmunt, J[Bellmunt, Joaquim]
- Issue Date
- 20-May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.